Fig 1.
The Registers included in the study.
Fig 2.
Flowchart of the study population.
Table 1.
Maternal, fetal and delivery characteristics and diagnosis of labor dystocia in nulliparous and parous women with singleton infants in cephalic presentation, term or post-term births with induction or spontaneous onset of delivery, in Sweden, April 2006-December 2011.
Table 2.
Use of LMWH during pregnancy and eligible underlying diagnoses.
Fig 3.
Gestational length at birth (weeks) and use of LMWH during pregnancy, all deliveries.
Table 3.
Regression analysis of use of LMWH during pregnancy and diagnosis of labor dystocia in nulliparous and parous women with singleton infants in cephalic presentation, term or post-term births with induction or spontaneous onset of delivery, in Sweden, April 2006 -December 2011.
Table 4.
Use of LMWH, divided by presumed high dose and presumed prophylactic dose in third trimester compared to no treatment, and labor dystocia. Women with treatment in first and/or second trimester are excluded.